Overview
Song Wang practices practicing medicine in Lanzhou, China.
Their clinical expertise encompasses Bernard-Soulier Syndrome, Peutz-Jeghers Syndrome, Melasma, and Stomach Cancer.
They are actively involved in clinical research, co-authoring 14 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Song Wang
Is Song Wang a top-rated expert for Bernard-Soulier Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Song Wang is classified as an Experienced expert for Bernard-Soulier Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Song Wang participate in research or clinical trials?
Yes. Song Wang has published 14 articles and abstracts on conditions like Bernard-Soulier Syndrome. You can view a list of Song Wang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bernard-Soulier SyndromeWang isExperienced. Learn about Bernard-Soulier Syndrome.
- MelasmaWang isExperienced. Learn about Melasma.
- Peutz-Jeghers SyndromeWang isExperienced. Learn about Peutz-Jeghers Syndrome.
- Stomach CancerWang isExperienced. Learn about Stomach Cancer.